Loading...

Buy Full Version
"Patient Monitoring Devices Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Patient Monitoring Devices Market by Product (Hemodynamic, Neuromonitoring, Cardiac, Fetal & Neonatal, Respiratory, Multiparameter, Remote Patient, Weight, Temperature, and Urine Output Monitoring Devices), and End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

LI_171663
Pages: 267
Mar 2019 | 7116 Views
 
Author(s) : Tenzin Kunsel and Surabhi Pandey
Tables: 93
Charts: 56
 

Patient Monitoring Devices Market Outlook - 2025

According to a study by Elliot and Coventry, it is important that the following eight parameters of a patient be monitored: oxygen saturation, blood pressure, temperature, pain, pulse, level of consciousness, urine output, and respiration rate, which are monitored with the help of patient monitoring devices.

Patient monitoring devices are used during minor & major surgeries to monitor a patient’s physiological signs and related complications. Moreover, with the advancements in wireless technology, these devices can be used to remotely monitor the physiological parameters of the patients. These devices are a critical part of hospitals and other healthcare facilities as these are expected to help physicians determine the severity of a disease. These devices help doctors and other healthcare professionals detect and monitor the health of the patients suffering from various types of diseases such as diabetes and cardiovascular diseases. The global patient monitoring devices market size was valued at $22,641 million in 2017, and is estimated to reach $37,187 million by 2025, registering a CAGR of 6.4% from 2018 to 2025.

Get more information on this report : Request Sample Pages

The major driving factors for the growth of patient monitoring devices industry are rise in the prevalence of lifestyle diseases such as diabetes, cancer, and atherosclerosis, and increase in the adoption rate of remote patient monitoring devices. Moreover, increase in the geriatric population is expected to fuel the patient monitoring devices market growth as elderly people are more prone to suffer from chronic and lifestyle diseases that require the use of these patient monitoring devices to assess their health. However, the cost associated with this technology and issues related to government regulations & reimbursements are expected to hamper the global patient monitoring devices market growth. With the advancement in wireless technology, these devices are used to remotely monitor the physiological parameters of the patients, such as blood glucose level, blood pressure, heart rate, and provide appropriate treatment to the patients. Thus, the technological advancements in these devices and the presence of untapped market in the developing region are expected to open new avenues for patient monitoring devices market opportunity.

Product type segment review

Based on product type, the global patient monitoring devices market is categorized into hemodynamic, neuromonitoring, cardiac, fetal & neonatal, respiratory, multiparameter, remote patient, weight, and temperature monitoring devices. Cardiac monitoring devices are further divided into electrocardiogram devices, Holter monitors, event monitors, and others (implantable loop recorders, cardiac output monitoring devices, and others). The cardiac monitoring devices segment dominated the patient monitoring devices market share in 2017, and is expected to continue its dominance throughout the forecast period. This is attributed to the rise in prevalence of cardiovascular disease where these devices can help monitor the severity. In addition, these devices can also be used in various applications during cardiovascular surgeries.

Get more information on this report : Request Sample Pages

End user segment review

Based on end users, the patient monitoring devices market is divided into hospitals & clinics, home settings, and ambulatory surgical centers. As per the global patient monitoring devices market forecast, the home setting segment is expected to be the fastest growing segment due to rise in awareness regarding benefits of using remote patient monitoring and the availability of using these devices from the comfort of homes.

Get more information on this report : Request Sample Pages

Key regional segment

As per region, the patient monitoring devices market analysis is across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2017 for growth of the patient monitoring devices market, and is expected to retain its dominance throughout the forecast period. However, Asia-Pacific possesses high market potential for growth of the patient monitoring devices market due to rise in the geriatric population and increase in the purchasing power of populous countries, such as China and Japan. The surge in the use of these devices has led to rapid developments in the patient monitoring devices market trends. Owing to the rise in the prevalence of lifestyle diseases, the governments of numerous countries have taken an initiative to improve the healthcare facilities by improving the overall healthcare infrastructure, which is expected to propel the patient monitoring devices market growth.

Get more information on this report : Request Sample Pages

The report of global patient monitoring devices market provides extensive competitive analysis and profiles of key market players, such as Medtronic, Inc., Biotronik, F. Hoffmann-La Roche Ltd., GE Healthcare Ltd., Masimo Corporation, Nihon Kohden Corporation, Johnson & Johnson, Omron Healthcare Co. Ltd., Abbott Laboratories, and Koninklijke Philips N.V.
The other players in the value chain that provides patient monitoring devices market include Honeywell International Inc., Siemens Healthcare, Lifewatch AG, Care Innovations, LLC., Smiths Medical, and St. Jude Medical, Inc.

Key Benefits for Patient Monitoring Devices Market:

  • This report entails a detailed quantitative analysis of the market trends from 2018 to 2025 to identify the prevailing opportunities.
  • Market estimations are based on a comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to product type, end user, and region.
  • An in-depth analysis based on region helps to understand the regional market to assist in strategic business planning.
  • The development strategies adopted by the key manufacturers are enlisted to understand the competitive scenario of the market.

Patient Monitoring Devices Key Market Segments:

By Product

  • Hemodynamic Monitoring Devices
    • Blood Glucose
    • Cholesterol
    • Blood Gas & Electrolyte Analyzers/Monitors
    • Blood Pressure
  • Neuromonitoring Devices
    • Electroencephalograph (EEG) Devices
    • Magnetoencephalograph (MEG) Devices
    • Intracranial Pressure Monitors (ICP)
    • Transcranial Dopplers (TCD)
    • Cerebral Oximeters
  • Cardiac Monitoring Devices
    • Electrocardiogram (ECG) Devices
    • Implantable Loop Recorders (ILR)
    • Cardiac Output Monitoring (COM) Devices
    • Event Monitors
  • Fetal & Neonatal Monitoring Devices
    • Ultrasound
    • Electronic Fetal Monitoring Devices
    • Fetal Doppler Monitoring Devices
    • Other Fetal & Neonatal Monitoring Devices
  • Respiratory Monitoring Devices
    • Capnographs
    • Anesthesia Monitors
    • Spirometers
    • Pulse Oximeters
    • Sleep Apnea Monitoring Devices
  • Multiparameter Monitoring Devices
    • High Acuity
    • Mid Acuity
    • Low Acuity
  • Remote Patient Monitoring Devices
  • Weight Monitoring Devices
  • Temperature Monitoring Devices
  • Urine Output Monitoring Devices

By End User

  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers (ASC)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Venezuela
    • Republic of South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets
3.2.2.    Top winning strategies

3.3.    Government regulations

3.3.1.    U.S. FDA
3.3.2.    Europe CE mark
3.3.3.    Ministry of Health, Labor, and Welfare (MHLW)

3.4.    Reimbursement scenarios
3.5.    Clinical trials
3.6.    Patent analysis

3.6.1.    U.S. patent analysis, by market participant
3.6.2.    Europe patent analysis, by market participant
3.6.3.    China patent analysis, by market participant
3.6.4.    Canada patent analysis, by market participant
3.6.5.    Japan patent analysis by market participant
3.6.6.    Other countries patent analysis, by market participant

3.7.    Top impacting factors
3.8.    Market Dynamics

3.8.1.    Drivers

3.8.1.1.    Rise in the prevalence of lifestyle diseases
3.8.1.2.    Increase in the geriatric population
3.8.1.3.    Rise in the adoption rate of remote patient monitoring devices

3.8.2.    Restrains

3.8.2.1.    Government regulations and reimbursement issues
3.8.2.2.    Limited awareness and high costs

3.8.3.    Opportunities

3.8.3.1.    Untapped markets in developing countries
3.8.3.2.    Technological advancements

CHAPTER 4:    PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Hemodynamic monitoring devices

4.2.1.    Key market trends
4.2.2.    Key growth factors and opportunities
4.2.3.    Market size and forecast
4.2.4.    Blood glucose monitors

4.2.4.1.    Market size and forecast

4.2.5.    Blood gas and electrolyte analyzers/monitors

4.2.5.1.    Market size and forecast

4.2.6.    Blood pressure monitors

4.2.6.1.    Market size and forecast

4.3.    Neuromonitoring devices

4.3.1.    Key market trends
4.3.2.    Key growth factors and opportunities
4.3.3.    Market size and forecast
4.3.4.    Electroencephalograph (EEG) devices

4.3.4.1.    Market size and forecast

4.3.5.    Transcranial dopplers (TCD)

4.3.5.1.    Market size and forecast

4.3.6.    Magnetoencephalograph (MEG) devices

4.3.6.1.    Market size and forecast

4.3.7.    Intracranial pressure monitors (ICP)

4.3.7.1.    Market size and forecast

4.3.8.    Cerebral oximeters

4.3.8.1.    Market size and forecast

4.4.    Cardiac monitoring devices

4.4.1.    Key market trends
4.4.2.    Key growth factors and opportunities
4.4.3.    Market size and forecast
4.4.4.    Electrocardiogram (ECG) devices

4.4.4.1.    By type
4.4.4.2.    By lead type
4.4.4.3.    Market size and forecast

4.4.5.    Holter monitors

4.4.5.1.    Market size and forecast

4.4.6.    Event monitors

4.4.6.1.    By type
4.4.6.2.    By technology
4.4.6.3.    Market size and forecast

4.4.7.    Others (Implantable loop recorder, Cardiac output monitor and others)

4.4.7.1.    Market size and forecast

4.5.    Fetal and neonatal monitoring devices

4.5.1.    Key market trends
4.5.2.    Key growth factors and opportunities
4.5.3.    Market size and forecast
4.5.4.    Ultrasound

4.5.4.1.    Market size and forecast

4.5.5.    Electronic Fetal Monitoring Devices

4.5.5.1.    Market size and forecast

4.5.6.    Fetal Doppler Monitoring Devices

4.5.6.1.    Market size and forecast

4.5.7.    Other Fetal and Neonatal Monitoring Devices

4.5.7.1.    Market size and forecast

4.6.    Respiratory monitors

4.6.1.    Key market trends
4.6.2.    Key growth factors and opportunities
4.6.3.    Market size and forecast
4.6.4.    Capnographs

4.6.4.1.    Market size and forecast

4.6.5.    Pulse oximeters

4.6.5.1.    Market size and forecast

4.6.6.    Sleep apnea monitors

4.6.6.1.    Market size and forecast

4.6.7.    Spirometers

4.6.7.1.    Market size and forecast

4.7.    Multiparameter monitoring devices

4.7.1.    Key market trends
4.7.2.    Key growth factors and opportunities
4.7.3.    Market size and forecast
4.7.4.    High acuity

4.7.4.1.    Market size and forecast

4.7.5.    Mid acuity

4.7.5.1.    Market size and forecast

4.7.6.    Low acuity

4.7.6.1.    Market size and forecast

4.8.    Remote patient monitoring devices

4.8.1.    Key market trends
4.8.2.    Key growth factors and opportunities
4.8.3.    Market size and forecast

4.9.    Weight monitoring devices

4.9.1.    Key market trends
4.9.2.    Key growth factors and opportunities
4.9.3.    Market size and forecast

4.10.    Temperature monitoring devices

4.10.1.    Key market trends
4.10.2.    Key growth factors and opportunities
4.10.3.    Market size and forecast

4.11.    Urine output monitoring

4.11.1.    Key market trends
4.11.2.    Key growth factors and opportunities
4.11.3.    Market size and forecast

CHAPTER 5:    PATIENT MONITORING DEVICES MARKET, BY END USER

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Hospitals

5.2.1.    Market size and forecast

5.3.    Home settings

5.3.1.    Market size and forecast

5.4.    Ambulatory surgical centers (ASC)

5.4.1.    Market size and forecast

CHAPTER 6:    PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    North America

6.2.1.    Market size and forecast

6.2.1.1.    U.S. market size and forecast
6.2.1.2.    Canada market size and forecast
6.2.1.3.    Mexico market size and forecast

6.3.    Europe

6.3.1.    Market size and forecast

6.3.1.1.    Germany market size and forecast
6.3.1.2.    France market size and forecast
6.3.1.3.    UK market size and forecast
6.3.1.4.    Italy market size and forecast
6.3.1.5.    Spain market size and forecast
6.3.1.6.    Rest of Europe market size and forecast

6.4.    Asia-Pacific

6.4.1.    Market size and forecast

6.4.1.1.    Japan market size and forecast
6.4.1.2.    China market size and forecast
6.4.1.3.    Australia market size and forecast
6.4.1.4.    India market size and forecast
6.4.1.5.    South Korea market size and forecast
6.4.1.6.    Rest of Asia-Pacific market size and forecast

6.5.    LAMEA

6.5.1.    Market size and forecast

6.5.1.1.    Brazil market size and forecast
6.5.1.2.    Turkey market size and forecast
6.5.1.3.    Venezuela market size and forecast
6.5.1.4.    Saudi Arabia market size and forecast
6.5.1.5.    Rest of LAMEA market size and forecast

CHAPTER 7:    COMPANY PROFILES

7.1.    Abbott Laboratories

7.1.1.    Company overview
7.1.2.    Company snapshot
7.1.3.    Operating business segments
7.1.4.    Product portfolio
7.1.5.    Business performance
7.1.6.    Key strategic moves and developments

7.2.    Biotronik SE & Co. KG

7.2.1.    Company overview
7.2.2.    Company snapshot
7.2.3.    Operating business segments
7.2.4.    Product portfolio
7.2.5.    Key strategic moves and developments

7.3.    General Electric Company (GE Healthcare)

7.3.1.    Company overview
7.3.2.    Company snapshot
7.3.3.    Operating business segments
7.3.4.    Product portfolio
7.3.5.    Business performance
7.3.6.    Key strategic moves and developments

7.4.    F. Hoffmann-La Roche Ltd.

7.4.1.    Company overview
7.4.2.    Company snapshot
7.4.3.    Operating business segments
7.4.4.    Product portfolio
7.4.5.    Business performance
7.4.6.    Key strategic moves and developments

7.5.    Johnson & Johnson

7.5.1.    Company overview
7.5.2.    Company snapshot
7.5.3.    Operating business segments
7.5.4.    Product portfolio
7.5.5.    Business performance
7.5.6.    Key strategic moves and developments

7.6.    Koninklijke Philips N.V. (Philips Healthcare)

7.6.1.    Company overview
7.6.2.    Company snapshot
7.6.3.    Operating business segments
7.6.4.    Product portfolio
7.6.5.    Business performance
7.6.6.    Key strategic moves and developments

7.7.    Masimo Corporation

7.7.1.    Company overview
7.7.2.    Company snapshot
7.7.3.    Product portfolio
7.7.4.    Business performance
7.7.5.    Key Strategic Moves:

7.8.    Medtronic Plc. (Covidien Ltd.)

7.8.1.    Company overview
7.8.2.    Company snapshot
7.8.3.    Operating business segments
7.8.4.    Product portfolio
7.8.5.    Business performance
7.8.6.    Key strategic moves and developments

7.9.    Nihon Kohden Corporation

7.9.1.    Company overview
7.9.2.    Company snapshot
7.9.3.    Operating business segments
7.9.4.    Product portfolio
7.9.5.    Business performance
7.9.6.    Key strategic moves and developments

7.10.    Omron Corporation

7.10.1.    Company overview
7.10.2.    Company snapshot
7.10.3.    Operating business segments
7.10.4.    Product portfolio
7.10.5.    Business performance
7.10.6.    Key Strategic Moves:

LIST OF TABLES

TABLE 01.    CLINICAL TRIALS: PATIENT MONITORING DEVICES MARKET, 2013–2016
TABLE 02.    PATENTS REGISTERED/APPROVED IN THE WORLD 2010-2016
TABLE 03.    U.S. PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010- 2016
TABLE 04.    EUROPE PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 05.    CHINA PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 06.    CANADA PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 07.    JAPAN PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 08.    OTHERS PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 09.    GLOBAL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 10.    HEMODYNAMIC MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 11.    HEMODYNAMIC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 12.    BLOOD GLUCOSE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 13.    BLOOD GAS & ELECTROLYTE ANALYSERS MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 14.    BLOOD PRESSURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 15.    NEUROMONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 16.    NEUROMONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 17.    ELECTROENCEPHALOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 18.    TRANSCRANIAL DOPPLERS MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 19.    MAGNETOENCEPHALOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 20.    INTRACRANIAL PRESSURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 21.    CEREBRAL OXIMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 22.    CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 23.    CARDIAC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 24.    ELECTROCARDIOGRAM MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 25.    HOLTER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 26.    EVENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 27.    OTHER CARDIAC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 28.    FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 29.    FETAL AND NEONATAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 30.    ULTRASOUND MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 31.    ELECTRONIC FETAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 32.    FETAL DOPPLER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 33.    OTHER FETAL AND NEONATAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 34.    RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 35.    RESPIRATORY MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 36.    CAPNOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 37.    PULSE OXIMETER MONITORING DEVICES MARKET, BY GEOGRAPHY,  2017–2025 ($MILLION)
TABLE 38.    SLEEP APNEA MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 39.    SPIROMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 40.    MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 41.    MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 42.    HIGH ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 43.    MID ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 44.    LOW ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 45.    REMOTE PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 46.    WEIGHT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 47.    TEMPERATURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 48.    PATIENT MONITORING DEVICES MARKET FOR URINE MONITORING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 49.    GLOBAL PATIENT MONITORING DEVICES MARKET, BY END USERS, 2017–2025 ($MILLION)
TABLE 50.    PATIENT MONITORING DEVICES MARKET IN HOSPITALS, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 51.    PATIENT MONITORING DEVICES MARKET IN HOME SETTING, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 52.    PATIENT MONITORING DEVICES MARKET IN AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 53.    PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 54.    NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55.    NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 56.    NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 57.    EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 58.    EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 59.    EUROPE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 60.    ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 61.    ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 62.    ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 63.    LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64.    LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 65.    LAMEA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 66.    ABBOTT: COMPANY SNAPSHOT
TABLE 67.    ABBOTT: OPERATING SEGMENTS
TABLE 68.    ABBOTT: PRODUCT PORTFOLIO
TABLE 69.    BIOTRONIK: COMPANY SNAPSHOT
TABLE 70.    BIOTRONIK: OPERATING SEGMENTS
TABLE 71.    BIOTRONIK: PRODUCT PORTFOLIO
TABLE 72.    GE: COMPANY SNAPSHOT
TABLE 73.    GE: OPERATING SEGMENTS
TABLE 74.    GE: PRODUCT PORTFOLIO
TABLE 75.    ROCHE: COMPANY SNAPSHOT
TABLE 76.    ROCHE: OPERATING SEGMENTS
TABLE 77.    ROCHE: PRODUCT PORTFOLIO
TABLE 78.    J&J: COMPANY SNAPSHOT
TABLE 79.    J&J: OPERATING SEGMENTS
TABLE 80.    J&J: PRODUCT PORTFOLIO
TABLE 81.    PHILIPS: COMPANY SNAPSHOT
TABLE 82.    PHILIPS: OPERATING SEGMENTS
TABLE 83.    PHILIPS: PRODUCT PORTFOLIO
TABLE 84.    MASIMO: COMPANY SNAPSHOT
TABLE 85.    MASIMO: PRODUCT PORTFOLIO
TABLE 86.    MEDTRONIC: COMPANY SNAPSHOT
TABLE 87.    MEDTRONIC: OPERATING SEGMENTS
TABLE 88.    MEDTRONIC: PRODUCT PORTFOLIO
TABLE 89.    NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 90.    GSK: PRODUCT PORTFOLIO
TABLE 91.    OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 92.    OMRON CORPORATION: OPERATING SEGMENTS
TABLE 93.    OMRON CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    TOP INVESTMENT POCKETS: GLOBAL PATIENT MONITORING DEVICES MARKET, BY DEVICE TYPE
FIGURE 02.    TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014–2016)
FIGURE 03.    TOP WINNING STRATEGIES: NATURE AND TYPE (2014-2016)
FIGURE 04.    PATENTS REGISTERED/APPROVED IN THE WORLD 2010-2016
FIGURE 05.    U.S. PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
FIGURE 06.    EUROPE PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
FIGURE 07.    CHINA PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
FIGURE 08.    CANADA PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
FIGURE 09.    JAPAN PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016
FIGURE 10.    OTHERS PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010- 2016
FIGURE 11.    TOP IMPACTING FACTORS
FIGURE 12.    U.S. PATIENT MONITORING MARKET, 2017–2025
FIGURE 13.    CANADA PATIENT MONITORING MARKET, 2017–2025
FIGURE 14.    MEXICO PATIENT MONITORING MARKET, 2017–2025
FIGURE 15.    GERMANY PATIENT MONITORING MARKET, 2017–2025
FIGURE 16.    FRANCE PATIENT MONITORING MARKET, 2017–2025
FIGURE 17.    UK PATIENT MONITORING MARKET, 2017–2025
FIGURE 18.    ITALY PATIENT MONITORING MARKET, 2017–2025
FIGURE 19.    SPAIN PATIENT MONITORING MARKET, 2017–2025
FIGURE 20.    REST OF EUROPE PATIENT MONITORING MARKET, 2017–2025
FIGURE 21.    JAPAN PATIENT MONITORING MARKET, 2017–2025
FIGURE 22.    CHINA PATIENT MONITORING MARKET, 2017–2025
FIGURE 23.    AUSTRALIA PATIENT MONITORING MARKET, 2017–2025
FIGURE 24.    INDIA PATIENT MONITORING MARKET, 2017–2025
FIGURE 25.    SOUTH KOREA PATIENT MONITORING MARKET, 2017–2025
FIGURE 26.    REST OF ASIA-PACIFIC PATIENT MONITORING MARKET, 2017–2025
FIGURE 27.    BRAZIL PATIENT MONITORING MARKET, 2017–2025
FIGURE 28.    TURKEY PATIENT MONITORING MARKET, 2017–2025
FIGURE 29.    VENEZUELA PATIENT MONITORING MARKET, 2017–2025
FIGURE 30.    SAUDI ARABIA PATIENT MONITORING MARKET, 2017–2025
FIGURE 31.    REST OF LAMEA PATIENT MONITORING MARKET, 2017–2025
FIGURE 32.    ABBOTT: NET SALES, 2015–2017 ($MILLION)
FIGURE 33.    ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34.    ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 35.    GE: NET SALES, 2015–2017 ($MILLION)
FIGURE 36.    GE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37.    GE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38.    ROCHE: NET SALES, 2015–2017 ($MILLION)
FIGURE 39.    ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40.    J&J: NET SALES, 2017–2016 ($MILLION)
FIGURE 41.    J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42.    J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43.    PHILIPS: NET SALES, 2015–2017 ($MILLION)
FIGURE 44.    PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45.    PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46.    MASIMO: NET SALES, 2016-2018 ($MILLION)
FIGURE 47.    MASIMO: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 48.    MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 49.    MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 50.    MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 51.    NIHON KOHDEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 52.    NIHON KOHDEN: REVENUE SHARE BY PRODUCT SEGMENT, 2018 (%)
FIGURE 53.    NIHON KOHDEN: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 54.    OMRON CORPORATION: NET SALES, 2015–2017 ($MILLION)
FIGURE 55.    OMRON CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 56.    OMRON CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 
 

Patient monitoring devices are used to monitor, measure, and record various physiological parameters of the patient. The cardiac monitoring devices are expected to gain popularity and dominate the market, owing to rise in the prevalence of various cardiac diseases, which is expected to account for major revenue generation during the forecast period. The remote patient monitoring devices segment is estimated to grow at the highest rate, owing to the rise in awareness about the several benefits such as shortened hospital stay, improvement in the clinical outcomes, and reduced hospital readmissions, rise in the incidence of lifestyle diseases, and increase in the geriatric population.

Various advancements in the patient monitoring technology, such as improvement in performance, utility, usability, sensitivity, and decrease in the size of the device are expected to boost the market growth. The untapped regions, such as China and India, are expected to emerge as the lucrative market, owing to the growth in demand and awareness of patient monitoring devices.

The employment of patient monitoring devices is highest in North America, owing to the increase in adoption of these devices, high awareness regarding the benefits of these devices among the healthcare providers, and rise in disposable income among patients. Although the use of patient monitoring devices in Asia-Pacific and LAMEA is low, the adoption rate is expected to increase, owing to rapid urbanization, rise in disposable incomes, improved government funding toward healthcare, and growth in awareness about various lifestyle diseases.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
Patient Monitoring Devices Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 
image image image image image image image image image image image image image image image image image image image
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample